Bromhexine Hydrochloride Tablets for the Treatment of Moderate COVID‐19: An Open‐Label Randomized Controlled Pilot Study

This open‐label randomized controlled pilot study aimed to test the study feasibility of bromhexine hydrochloride (BRH) tablets for the treatment of mild or moderate coronavirus disease 2019 (COVID‐19) and to explore its clinical efficacy and safety. Patients with mild or moderate COVID‐19 were rand...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Transl Sci
Autori principali: Li, Ting, Sun, Laifang, Zhang, Wenwu, Zheng, Chanfan, Jiang, Chenchen, Chen, Mingjing, Chen, Di, Dai, Zhijuan, Bao, Shihui, Shen, Xian
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2020
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7719397/
https://ncbi.nlm.nih.gov/pubmed/32881359
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cts.12881
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi